Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4876604 | 0.99 | TRPV3 (0.31) | TRPV3 | |
| SCHEMBL4883772 | 0.77 | — | — | |
| SCHEMBL4879686 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL4885433 | 0.72 | — | — | |
| SCHEMBL4876601 | 0.64 | — | — | |
| SCHEMBL7434489 | 0.64 | PDE5A (0.34) | — | |
| SCHEMBL6979264 | 0.63 | MEN1 (0.36) | — | |
| SCHEMBL6153485 | 0.63 | ADORA1 (0.36) | — | |
| SCHEMBL9082502 | 0.63 | ADORA2A (0.40) | — | |
| SCHEMBL9083885 | 0.63 | ADORA2A (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080161327-A1 | Substituted 9-Alkyladenines and the Use Thereof | ADERIS PHARMACEUTICALS, INC. (US) | 2008-07-03 | — | — | US | claimed |
| EP-1863815-A1 | SUBSTITUTED 9-ALKYLADENINES AND THE USE THEREOF | Aderis Pharmaceuticals, Inc. (US) | 2007-12-12 | — | — | EP | claimed |
| WO-2006099204-A1 | SUBSTITUTED 9-ALKYLADENINES AND THE USE THEREOF | ADERIS PHARMACEUTICALS, INC. (US) | 2006-09-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161327-A1 | Substituted 9-Alkyladenines and the Use Thereof | ADORA1, ADORA2A, ADORA3 | TRPV3 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.